symbol,name,description,country,year,period,documentUrl,income,expenses,postedName,date,clientId,registrantId,senateId,houseRegistrantId
AXGN,"AXOGEN, INC.",Regenerative medicine,US,2022,Q2,https://lda.senate.gov/filings/public/filing/4e2a52a1-33a6-48a4-8a22-826368f73563/print/,10000,,,,51519,401106069,401106069-51519,401106069
AXGN,"AXOGEN, INC.",Regenerative medicine,US,2022,Q3,https://lda.senate.gov/filings/public/filing/62b5a2d8-2ebd-48e6-a01b-1969d8d811f3/print/,10000,,,,51519,401106069,401106069-51519,401106069
AXGN,"AXOGEN, INC.",Regenerative medicine,US,2022,Q4,https://lda.senate.gov/filings/public/filing/bce6b5a4-9896-4e52-ac22-90a8dfa5fe4e/print/,10000,,,,51519,401106069,401106069-51519,401106069
